Cleveland Clinic | 12th Annual Obesity Summit
Avatar

Management of Hypertension and Hyperlipidemia in Type 2 Diabetes

By Cleveland Clinic | 12th Annual Obesity Summit FEATURING Steven Nissen
December 2017
1 Comment
Login to view comments. Click here to Login

Featured Video

15:44
Radius Health

Postmenopausal Osteoporosis in Women at High Risk for Fracture: A Sequen...

Feat. F. Cosman

Related Content

AUTOPLAY
Didactic Presentations

Cardiovascular Update for the Primary Care Provider

Thu, Oct 24, 2019
See 3 others
Didactic Presentations

3rd Philadelphia Cardiovascular Summit

Fri, Nov 1, 2019
Didactic Presentations

3rd Annual Montefiore Einstein Preventive Cardiology Conference

Sat, Nov 2, 2019
Didactic Presentations

24th Pan Arab Conference on Diabetes

Fri, Mar 27, 2020
16:56
William White

Ambulatory Blood Pressure Monitoring

28:09
ASPC 2019 Congress on CVD Prevention

LDL-C lowering and the Brain: Differentiating Fact from Fiction

Feat. P. Toth
18:26
ARCH Advanced Revascularization Symposium

Hypertension 2016: Guidelines and Updates

21:02
Northwestern Medicine: 8th Annual Cardiovascular Update

What's New and Why- Cholesterol Guidelines

Feat. N. Stone
26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibition

Feat. R. DeFronzo
15:25
Javed Butler

SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus

28:13
National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty Aci...

Feat. R. Mason
27:02
ASPC 2019 Congress on CVD Prevention

Expanded use of CAC testing in 2018 Cholesterol Guidelines- How to Apply?

Feat. R. Blankstein
28:22
Richard Auchus

Primary Aldosteronism and Implications for Primary Hypertension

45:19
ASPC 2019 Congress on CVD Prevention

REDUCE-IT and Treating Beyond LDL-C Lowering

Feat. D. Bhatt
18:42
Bonita Falkner

Recent Advances in Pediatric Hypertension

13:42
George Bakris

Current Status of Prevention and Treatment of Diabetic Nephropathy

04:42
Cleveland Clinic Heart and Vascular Institute

Heart Outcomes Prevention Evaluation–3 - HOPE-3 Trial

Feat. S. Nissen
29:14
Michael Ozner

The Role of Omega-3 Fatty Acids for the Treatment and Prevention of Card...

21:16
National Lipid Association

Pearls from 34 Years of Running a Lipid Clinic

Feat. A. Brown
07:03
UC Davis Health Diabetes and Endocrinology Symposium

Diabetes and the Kidney

Feat. S. Ananthakrishnan
14:18
Richard Heuser

Immediate Blood Pressure Response: Non-Vascular Treatment for Resistant ...

16:12
ASPC 2018 Congress on CVD Prevention

Debate – Pro – Lipoprotein(a) – Should Be Measured In All Patients At Hi...

Feat. P. Moriarty
22:53
George Bakris

Renal Effects of Diabetes

53:27
Savitha Subramanian

Lipid Lowering: The Story Beyond Statins